Resolve Biosciences is a biotechnology research company for molecular cartography.
Resolve BioSciences has raised $71.0M in total funding. The most recent round was Series B. The last funding was announced in October 2022.
Resolve BioSciences's investors include HTGF (High-Tech Gruenderfonds), NRW.BANK, Patient Square Capital, EDBI, Alafi Capital.
Resolve BioSciences is headquartered in Düsseldorf, Germany.
Resolve Biosciences is a biotechnology research company for molecular cartography.
Resolve BioSciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resolve BioSciences — Funding & Investors." VCBacked, October 24, 2022, https://www.vcbacked.co/company/resolve-biosciences. Accessed August 13, 2026.
VCBacked. (2022). Resolve BioSciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/resolve-biosciences
{{cite web |title=Resolve BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/resolve-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated